This study provides strong evidence that a 3-gene signature model, combining CDH4 and STAT4 and EBV-encoded LMP1, has a significant differentiating power to separate NPC from normal nasopharyngeal samples and predicting disease malignancy. The gene discussed is CDH4; the disease is nasopharyngeal carcinoma.